SCHEMBL25873193

SCHEMBL25873193

COC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(C)cc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.80
AKR1C3 P42330 4/20 0.80
CNR2 P34972 1/20 0.80
AKR1C2 P52895 2/20 0.72
LMNA P02545 2/20 0.65
ALDH1A1 P00352 1/20 0.65
HPGD P15428 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
PTGS1 P23219 3/20 0.65
MAPT P10636 2/20 0.65
GLO1 Q04760 2/20 0.65
HIF1A Q16665 2/20 0.65
KDM4E B2RXH2 1/20 0.65
MEN1 O00255 1/20 0.65
PTGES O14684 1/20 0.65
ABCC3 O15438 1/20 0.65
ABCC4 O15439 1/20 0.65
ABCB11 O95342 1/20 0.65
MT-CO2 P00403 1/20 0.65
ALB P02768 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13448804 0.93 AKR1C3 (0.83) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL20259423 0.90 PTGS2 (0.78) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL20346373 0.90 PTGS2 (0.79) PTGS2AKR1C3CNR2PTGS1GLO1
SCHEMBL30426824 0.89 PTGS2 (1.00) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL14086813 0.89 PTGS2 (1.00) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL17369560 0.88 PTGS2 (0.64) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL10549590 0.87 PTGS2 (0.80) PTGS2AKR1C3AKR1C2LMNAPTGS1
SCHEMBL17369544 0.87 PTGS2 (0.66) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL17945899 0.87 PTGS2 (0.66) PTGS2AKR1C3CNR2AKR1C2LMNA
SCHEMBL27768669 0.85 AKR1C3 (0.78) PTGS2AKR1C3CNR2AKR1C2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227425-A1 REAGENTS AND PROCESS FOR DIRECT C-H FUNCTIONALIZATION STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227425-A1 REAGENTS AND PROCESS FOR DIRECT C-H FUNCTIONALIZATION CFH, DOHH, CTSH PTGS2 3723/4885AKR1C3 598/4885CNR2 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.